HTG Molecular Diagnostics, Inc. Stock

HTGMQ

US40434H3021

Advanced Medical Equipment & Technology

Delayed OTC Markets 15:03:16 2026-08-20 EDT			5-day change	1st Jan Change
0.000100 ^USD	+9,900.00%		+9,900.00%	-

25-05-21	Motion For Case Conversion Approved for HTG Molecular Diagnostics, Inc.	CI
25-04-27	Motion for Case Conversion Filed by HTG Molecular Diagnostics, Inc.	CI

Valuation: HTG Molecular Diagnostics, Inc.

Market Cap	2.88K 2.47K 2.31K 2.11K 3.98K 274K 4.02K 27.26K 10.61K 138K 10.81K 10.57K 458K	P/E 2021	-2.19x	P/E 2022	-0.16x
Enterprise Value	-3.41M -2.92M -2.74M -2.5M -4.72M -325M -4.77M -32.29M -12.57M -164M -12.8M -12.52M -543M	EV / Sales 2021	3.96x	EV / Sales 2022	0.04x
Free-Float	99.86%	Yield 2021 *	-	Yield 2022	-

* Estimated data More valuation ratios

Chart: HTG Molecular Diagnostics, Inc.

Dynamic Chart

Latest news : HTG Molecular Diagnostics, Inc.

25-05-21	Motion For Case Conversion Approved for HTG Molecular Diagnostics, Inc.	CI
25-04-27	Motion for Case Conversion Filed by HTG Molecular Diagnostics, Inc.	CI
23-08-25	Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc.	CI
23-08-16	Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc.	CI
23-07-21	Trustee/Examiner Appointed Under Chapter 11 for HTG Molecular Diagnostics, Inc.	CI
23-06-14	HTG Molecular Diagnostics, Inc.(OTCPK:HTGM.Q) dropped from NASDAQ Composite Index	CI
23-06-08	HTG Molecular Diagnostics, Inc.(NasdaqCM:HTGM) dropped from S&P TMI Index	CI
23-06-06	HTG MOLECULAR DIAGNOSTICS SHARES HIT RECORD LOW AFTER CO FILES F…	RE
23-06-05	Htg Molecular Diagnostics, Inc. Announces Termination of Employment of Byron T. Lawson as Senior Vice President and Chief Commercial Officer	CI
23-06-05	HTG Molecular Diagnostics, Inc. Filed for Bankruptcy	CI
23-05-18	HTG Molecular Diagnostics, Inc. to Highlight the Advantages of its Drug Discovery Engine at the 2023 Biotechnology Innovation Organization	CI
23-05-17	Top Premarket Gainers	MT
23-05-10	HTG Molecular Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

More news

Analysts' recommendations: HTG Molecular Diagnostics, Inc.

23-04-03	HC Wainwright Adjusts Price Target on HTG Molecular Diagnostics to $6 From $15, Maintains Buy Rating	MT
22-08-15	HC Wainwright Adjusts Price Target on HTG Molecular Diagnostics to $2 From $3, Reiterates Buy Rating	MT
22-05-16	HC Wainwright Adjusts HTG Molecular Diagnostics' Price Target to $3 from $4, Keeps Buy Rating	MT
22-03-30	Craig-Hallum Adjusts HTG Molecular Diagnostics' Price Target to $3 from $8, Keeps Buy Rating	MT
22-03-30	HC Wainwright Adjusts HTG Molecular Diagnostics' Price Target to $4 from $9, Keeps Buy Rating	MT

More recommendations

Press Releases: HTG Molecular Diagnostics, Inc.

23-06-08	HTG MOLECULAR DIAGNOSTICS, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
23-05-18	HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention	AQ
23-05-16	HTG Highlights the Advantages of Its Drug Discovery Engine	AQ
23-05-10	HTG Molecular Diagnostics : Reports First Quarter 2023 Results and Provides Recent Business Highlights - Form 8-K	PU
23-05-10	HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights	AQ

More press releases

Medical Diagnostic & Testing Equipment

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
HTG MOLECULAR DIAGNOSTICS, INC.	+9,900.00%	+9,900.00%	0.00%	-99.98%	221
SARTORIUS AG	+1.40%	+7.69%	+27.16%	-28.88%	17.58B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+15.78%	-1.96%	-31.69%	+101.93%	1.49B
QUIDELORTHO CORPORATION	+2.83%	+10.87%	-46.15%	-80.69%	994M
ECKERT & ZIEGLER SE	0.00%	-1.13%	-24.56%	+23.87%	962M
VAREX IMAGING CORPORATION	+0.03%	+0.38%	+62.54%	-5.41%	781M
CONTEC MEDICAL SYSTEMS CO.,LTD	+2.67%	-0.86%	-36.82%	-45.38%	671M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	+3.43%	-11.89%	-44.07%	-49.14%	544M
REVENIO GROUP OYJ	-0.54%	+2.50%	-39.43%	-33.78%	461M
908 DEVICES INC.	+0.46%	+8.63%	+74.64%	+51.87%	451M
Average	+992.58%	+1.84%	-5.84%	-16.56%	2.39B
Weighted average by Cap.	+2.30%	+3.42%	+15.73%	-19.50%

See all sector performances

HTG Molecular Diagnostics, Inc. is a life science company. The Company is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The Company's Gene Expression Panels include HTG Research Use Only (RUO) Panels and HTG EdgeSeq Research Use Only (RUO) Panels, such as the HTG Transcriptome Panel, HTG EdgeSeq miRNA Whole Transcriptome Assay, HTG EdgeSeq Oncology Biomarker Panel, HTG EdgeSeq Precision Immuno-Oncology Panel, HTG EdgeSeq Immune Response Panel, HTG EdgeSeq Pan B-Cell Lymphoma Panel, HTG EdgeSeq Mouse mRNA Tumor Response Panel, and HTG EdgeSeq DLBCL Cell of Origin Assay. The HTG EdgeSeq system provides gene expression profiling for researchers, laboratory staff, and biomarker leads in discovery, translational medicine, and oncology applications. VERI/O Laboratory Services is a molecular lab providing gene expression profiling results.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
26-08-20	US$0.000100	+9,900.00%	5,359

Delayed Quote OTC Markets

More quotes

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0.45
5 years	0		83.76
10 years	0		2,385

Date	Insider	Type	Main position	Quantity	% Market Cap.
6/8/23	Stephen Barat	Sell	Senior VP of Therapeutics	888	0.0401%
3/31/23	Stephen Barat	Tax	Senior VP of Therapeutics	52	0.0056%
2/2/23	Stephen Barat	Other	Senior VP of Therapeutics	7,610	0.8264%

	2021	2022
Net sales	8.91M 7.63M 7.15M 6.53M 12.33M 849M 12.45M 84.36M 32.84M 428M 33.44M 32.71M 1.42B	6.37M 5.46M 5.11M 4.67M 8.81M 607M 8.9M 60.29M 23.47M 306M 23.9M 23.38M 1.01B
Net income	-17.15M -14.69M -13.77M -12.57M -23.73M -1.63B -23.97M -162M -63.21M -825M -64.38M -62.97M -2.73B	-21.59M -18.5M -17.34M -15.84M -29.89M -2.06B -30.18M -205M -79.62M -1.04B -81.08M -79.32M -3.44B
Net Debt	-5.74M -4.92M -4.61M -4.21M -7.94M -547M -8.02M -54.33M -21.15M -276M -21.54M -21.07M -914M	-3.41M -2.92M -2.74M -2.5M -4.72M -325M -4.77M -32.31M -12.58M -164M -12.81M -12.53M -543M

HTG Molecular Diagnostics, Inc. Stock

Stocks

HTGMQ

US40434H3021

Advanced Medical Equipment & Technology

Valuation: HTG Molecular Diagnostics, Inc.

Chart: HTG Molecular Diagnostics, Inc.

Latest news : HTG Molecular Diagnostics, Inc.

Analysts' recommendations: HTG Molecular Diagnostics, Inc.

Press Releases: HTG Molecular Diagnostics, Inc.

Quotes and Performance

Course Extremes

Latest insider transactions

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

1 day	+9,900.00%
1 week	+9,900.00%
Current month	+9,900.00%
1 month	+9,900.00%
3 months	+9,900.00%
6 months	+9,900.00%